Sarepta Therapeutics, Inc. (SRPT)

NASDAQ: SRPT · Real-Time Price · USD

15.68

-0.20 (-1.26%)

At close: Jul 24, 2026, 4:00 PM EDT

15.70

+0.02 (0.13%)

After-hours: Jul 24, 2026, 7:58 PM EDT

Sarepta Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,184	2,198	1,902	1,243	933.01	701.89
Revenue Growth (YoY)	-2.20%	15.58%	52.97%	33.26%	32.93%	29.95%
Cost of Revenue	810.81	839.61	319.1	150.34	139.99	97.05
Gross Profit	1,373	1,359	1,583	1,093	793.02	604.84
Selling, General & Admin	467.04	491.72	557.87	481.87	451.42	282.66
Depreciation & Amortization Expenses	2.71	2.62	2.41	1.56	0.71	0.71
Research & Development	902.58	1,522	804.52	877.39	877.09	771.18
Other Operating Expenses	-	42.01	-	-	-	10
Total Operating Expenses	1,372	2,058	1,365	1,361	1,329	1,065
Operating Income	-40.96	-699.78	218.08	-267.82	-536.2	-459.71
Total Non-Operating Income (Expense)	48.57	-2.44	42.69	-252.27	-153.76	40.76
Pretax Income	24.47	-702.23	260.77	-520.1	-689.96	-418.95
Provision for Income Taxes	-40.59	11.19	25.54	15.88	13.53	-0.17
Net Income	65.06	-713.41	235.24	-535.98	-703.49	-418.78
Net Income to Common	65.06	-713.41	235.24	-535.98	-703.49	-418.78
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	102	100	95	92	88	81
Shares Outstanding (Diluted)	108	100	108	92	88	81
Shares Change (YoY)	6.94%	-7.19%	16.75%	5.53%	7.75%	4.24%
EPS (Basic)	-0.57	-7.13	2.47	-5.80	-8.03	-5.15
EPS (Diluted)	-0.96	-7.13	2.34	-5.80	-8.03	-5.15
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-372.29	-307.45	-342.74	-577.1	-356.17	-481.66
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-3.43	-3.07	-3.18	-6.25	-4.07	-5.93
Gross Margin	62.88%	61.81%	83.22%	87.91%	85.00%	86.17%
Operating Margin	-1.88%	-31.83%	11.47%	-21.54%	-57.47%	-65.50%
Profit Margin	2.98%	-32.45%	12.37%	-43.11%	-75.40%	-59.66%
FCF Margin	-17.04%	-13.99%	-18.02%	-46.42%	-38.17%	-68.62%
EBITDA	4.18	-655.26	235.37	-250.78	-494.34	-421.69
EBITDA Margin	0.19%	-29.81%	12.38%	-20.17%	-52.98%	-60.08%
EBIT	-40.96	-699.78	218.08	-267.82	-536.2	-459.71
EBIT Margin	-1.88%	-31.83%	11.47%	-21.54%	-57.47%	-65.50%
Effective Tax Rate	-165.90%	-1.59%	9.79%	-3.05%	-1.96%	0.04%

SEC Filings: 10-K · 10-Q